The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Neuropathological spectrum of synucleinopathies
Abstract
Synucleinopathies comprise a diverse group of neurodegenerative proteinopathies that share common pathological lesions composed of aggregates of conformational and posttranslational modifications of alpha-synuclein in selected populations of neurons and glia. Abnormal filamentous aggregates of misfolded alpha-synuclein protein are the major components of Lewy bodies, dystrophic (Lewy) neurites, and the Papp-Lantos filaments in oligodendroglia and neurons in multiple system atrophy linked to degeneration of affected brain regions. The synucleinopathies include (1) Lewy body disorders and dementia with Lewy bodies, (2) multiple system atrophy (MSA), and (3) Hallervorden-Spatz disease. (1) The pathological diagnosis of Lewy body disorders and dementia with Lewy bodies is established by validated consensus criteria based on semiquantitative assessment of subcortical and cortical Lewy bodies as their common hallmarks. They are accompanied by subcortical multisystem degeneration with neuronal loss and gliosis with or without Alzheimer pathologic state. Lewy bodies also occur in numerous other disorders, including pure autonomic failure, neuroaxonal dystrophies, and various amyloidoses and tauopathies. (2) Multiple system atrophy, a sporadic, adult-onset degenerative movement disorder of unknown cause, is characterized by alpha-synuclein-positive glial cytoplasmic and rare neuronal inclusions throughout the central nervous system associated with striatonigral degeneration, olivopontocerebellar atrophy, and involvement of medullar and spinal autonomic nuclei. (3) In neurodegeneration with brain iron accumulation type I, or Hallervorden-Spatz disease, alpha-synuclein is present in axonal spheroids and glial and neuronal inclusions. While the identity of the major components of Lewy bodies suggests that a pathway leading from normal soluble to abnormal misfolded filamentous proteins is central for their pathogenesis, regardless of the primary disorder, there are conformational differences in alpha-synuclein between neuronal and glial aggregates, showing nonuniform mapping for its epitopes. Despite several cellular and transgenic models, it is not clear whether inclusion body formation is an adaptive/neuroprotective or a pathogenic reaction/process generated in response to different, mostly undetermined, functional triggers linked to neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Alpha-synuclein and neurodegenerative diseases
Goedert, M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081564 · Cited by 1,408
Consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Low, P., Quinn, N., Albanese, A., Ben-Shlomo, Y., Fowler, C., Kaufmann, H., Klockgether, T., Lang, A., Lantos, P., et al. (1998) · Clinical Autonomic Research · doi:10.1007/bf02309628 · Cited by 1,308
Consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Low, P. A., Quinn, N., Albanese, A., Ben-Shlomo, Y., Fowler, C. J., Kaufmann, H., Klockgether, T., Lang, A. E., Lantos, P. L., et al. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00304-9 · Cited by 917
Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879
Where Does Parkinson Disease Pathology Begin in the Brain?
Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., & Hayflick, S. J. (2001) · Nature Genetics · doi:10.1038/ng572 · Cited by 752
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
Serpell, L. C., Berriman, J., Jakes, R., Goedert, M., & Crowther, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4897 · Cited by 748
Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., & Mucke, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211412398 · Cited by 607
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease
Hurtig, H. I., Trojanowski, J. Q., Galvin, J., Ewbank, D., Schmidt, M. L., Lee, V. M. Y., Clark, C. M., Glosser, G., Stern, M. B., Gollomp, S. M., et al. (2000) · Neurology · doi:10.1212/wnl.54.10.1916 · Cited by 601
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
LaVaute, T., Smith, S., Cooperman, S., Iwai, K., Land, W., Meyron-Holtz, E., Drake, S. K., Miller, G., Abu-Asab, M., Tsokos, M., et al. (2001) · Nature Genetics · doi:10.1038/84859 · Cited by 509
Bruyn, R. P. M. (2003) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(02)00110-5 · Cited by 509
Synucleinopathies: Clinical and Pathological Implications
Galvin, J. E., Lee, V. M.-Y., & Trojanowski, J. Q. (2001) · Archives of Neurology · doi:10.1001/archneur.58.2.186 · Cited by 466
Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies
McKeith, I. G., Ballard, C. G., Perry, R. H., Ince, P. G., O’Brien, J. T., Neill, D., Lowery, K., Jaros, E., Barber, R., Thompson, P., et al. (2000) · Neurology · doi:10.1212/wnl.54.5.1050 · Cited by 459
Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease
Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 443
Hallucinations, REM sleep, and Parkinson’s disease: A medical hypothesis
Arnulf, I., Bonnet, A.-M., Damier, P., Bejjani, B.-P., Seilhean, D., Derenne, J.-P., & Agid, Y. (2000) · Neurology · doi:10.1212/wnl.55.2.281 · Cited by 442
Microscopic analysis of polymerization dynamics with individual actin filaments
Fujiwara, I., Takahashi, S., Tadakuma, H., Funatsu, T., & Ishiwata, S. (2002) · Nature Cell Biology · doi:10.1038/ncb841 · Cited by 420
Parkinson Disease Neuropathology: Later-Developing Dementia and Loss of the Levodopa Response
Apaydin, H., Ahlskog, J. E., Parisi, J. E., Boeve, B. F., & Dickson, D. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.1.102 · Cited by 399
Tofaris, G. K., Layfield, R., & Spillantini, M. G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03115-5 · Cited by 363
Pattern of brain destruction in Parkinson's and Alzheimer's diseases
Braak, H., Braak, E., Yilmazer, D., de Vos, R. A. I., Jansen, E. N. H., & Bohl, J. (1996) · Journal of Neural Transmission · doi:10.1007/bf01276421 · Cited by 329
Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases
Duda, J. E., Giasson, B. I., Mabon, M. E., Lee, V. M. ‐., & Trojanowski, J. Q. (2002) · Annals of Neurology · doi:10.1002/ana.10279 · Cited by 329
Cortical Lewy body pathology in the diagnosis of dementia
Harding, A. J., & Halliday, G. M. (2001) · Acta Neuropathologica · doi:10.1007/s004010100390 · Cited by 297
Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease
Jellinger, K. A., Seppi, K., Wenning, G. K., & Poewe, W. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200027 · Cited by 287
Self-citationAlpha-synuclein and Parkinson's disease
Lücking, C. B., & Brice*, A. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000671 · Cited by 279
Walker, Z. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.2.134 · Cited by 279
Widespread Nitration of Pathological Inclusions in Neurodegenerative Synucleinopathies
Duda, J. E., Giasson, B. I., Chen, Q., Gur, T. L., Hurtig, H. I., Stern, M. B., Gollomp, S. M., Ischiropoulos, H., Lee, V. M.-Y., & Trojanowski, J. Q. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64781-5 · Cited by 277
Concurrence of α-synuclein and tau brain pathology in the Contursi kindred
Duda, J. E., Giasson, B. I., Mabon, M. E., Miller, D. C., Golbe, L. I., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0563-3 · Cited by 274
Campbell, B. C. V., McLean, C. A., Culvenor, J. G., Gai, W. P., Blumbergs, P. C., Jäkälä, P., Beyreuther, K., Masters, C. L., & Li, Q. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00021.x · Cited by 225
Chung, K. K. K., Dawson, V. L., & Dawson, T. M. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01998-6 · Cited by 222
Glucose Hypometabolism and Neuropathological Correlates in Brains of Dementia with Lewy Bodies
Higuchi, M., Tashiro, M., Arai, H., Okamura, N., Hara, S., Higuchi, S., Itoh, M., Shin, R.-W., Trojanowski, J. Q., & Sasaki, H. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7342 · Cited by 206
Beneficial effects of amantadine onL-dopa-induced dyskinesias in Parkinson's disease
Luginger, E., Wenning, G. K., B�sch, S., & Poewe, W. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<873::aid-mds1017>3.0.co;2-i · Cited by 203
The Definition of Multiple System Atrophy: A Review of Recent Developments
LANTOS, P. L. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199812000-00001 · Cited by 199
Galvin, J. E., Giasson, B., Hurtig, H. I., Lee, V. M.-Y., & Trojanowski, J. Q. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64548-8 · Cited by 194
Arai, Y., Yamazaki, M., Mori, O., Muramatsu, H., Asano, G., & Katayama, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03082-1 · Cited by 173
α-Synuclein and the Lewy body disorders
Dickson, D. W. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00001 · Cited by 164
Ma, S. Y., Röyttä, M., Rinne, J. O., Collan, Y., & Rinne, U. K. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00100-7 · Cited by 160
Recent developments in the pathology of Parkinson’s disease
Jellinger, K. A. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_33 · Cited by 157
Self-citationCriteria for Alzheimer's Disease and the Nosology of Dementia with Lewy Bodies
Hansen, L. A., & Samuel, W. (1997) · Neurology · doi:10.1212/wnl.48.1.126 · Cited by 150
Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study
Jellinger, K. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0676-3 · Cited by 139
Self-citationMechanistic Approaches to Parkinson's Disease Pathogenesis
Betarbet, R. S., Sherer, T., Monte, D. A. D., & Greenamyre, J. T. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00468.x · Cited by 137
Regional Distribution of α-Synuclein Pathology in Unimpaired Aging and Alzheimer Disease
Parkkinen, L., Soininen, H. S., & Alafuzoff, I. I. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.363 · Cited by 131
Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies
Gómez‐Isla, T., Growdon, W., McNamara, M. J., Newell, K. L., Gómez‐Tortosa, E., Hedley‐Whyte, E. T., & Hyman, B. T. (1999) · Neurology · doi:10.1212/wnl.53.9.2003 · Cited by 121
Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure
Kaufmann, H., Hague, K., & Perl, D. P. (2001) · Neurology · doi:10.1212/wnl.56.7.980 · Cited by 119
Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders
MNH (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.6.677 · Cited by 103
Yamazaki, M., Arai, Y., Baba, M., Iwatsubo, T., Mori, O., Katayama, Y., & Oyanagi, K. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.7.585 · Cited by 100
Ilinsky, I. A., & Kultas‐Ilinsky, K. (2002) · Movement Disorders · doi:10.1002/mds.10137 · Cited by 99
Gai, W. P., Pountney, D. L., Power, J. H. T., Li, Q. X., Culvenor, J. G., McLean, C., Jensen, P. H., & Blumbergs, P. C. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00004-9 · Cited by 97
Neumann, M., Adler, S., Schlüter, O. M., Kremmer, E., Benecke, R., & Kretzschmar, H. A. (2000) · Acta Neuropathologica · doi:10.1007/s004010000224 · Cited by 91
Jellinger, K. A. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0822-z · Cited by 85
Self-citationWakabayashi, K., Engelender, S., Tanaka, Y., Yoshimoto, M., Mori, F., Tsuji, S., Ross, C. A., & Takahashi, H. (2001) · Acta Neuropathologica · doi:10.1007/s004010100451 · Cited by 84
The genetic basis of Parkinson's disease
Foltynie, T., Sawcer, S., Brayne, C., & Barker, R. A. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.4.363 · Cited by 80
A novel grading scale for striatonigral degeneration (multiple system atrophy)
Wenning, G. K., Seppi, K., Tison, F., & Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200025 · Cited by 76
Self-citationFrontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia
Hansen, L. A., Daniel, S. E., Wilcock, G., & Love, S. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.5.653 · Cited by 76
Haroutunian, V. H., Serby, M., Purohit, D. P., Perl, D. P., Marin, D. B., Lantz, M., Mohs, R. C., & Davis, K. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.8.1145 · Cited by 71
Wakabayashi, K., Fukushima, T., Koide, R., Horikawa, Y., Hasegawa, M., Watanabe, Y., Noda, T., Eguchi, I., Morita, T., Yoshimoto, M., et al. (2000) · Acta Neuropathologica · doi:10.1007/s004010050049 · Cited by 64
The Metabolic Substrates of Bradykinesia and Tremor in Uncomplicated Parkinson's Disease
Lozza, C., Marié, R.-M., & Baron, J. (2002) · NeuroImage · doi:10.1006/nimg.2002.1245 · Cited by 58
Rinne, J. O., Nurmi, E., Ruottinen, H., Bergman, J., Eskola, O., & Solin, O. H. (2001) · Synapse · doi:10.1002/syn.1042 · Cited by 57
Improved Detection of Substantia Nigra Pathology in Alzheimer's Disease
Schneider, J. A., Bienias, J. L., Gilley, D. W., Kvarnberg, D. E., Mufson, E. J., & Bennett, D. A. A. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000111 · Cited by 57
New findings on the neuropathology of multiple system atrophy
Benarroch, E. E. (2002) · Autonomic Neuroscience · doi:10.1016/s1566-0702(01)00374-5 · Cited by 56
Sakamoto, M., Uchihara, T., Hayashi, M., Nakamura, A., Kikuchi, E., Mizutani, T., Mizusawa, H., & Hirai, S. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7961 · Cited by 49
Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls
Tsuboi, Y., Ahlskog, J. E., Apaydın, H., Parisi, J. E., & Dickson, D. W. (2001) · Neurology · doi:10.1212/wnl.57.9.1675 · Cited by 48
Simplified neuropathological diagnosis of dementia with Lewy bodies
Harding, & Halliday (1998) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1998.00115.x · Cited by 45
Prevalence of vascular lesions in Dementia with Lewy Bodies. A postmortem study
Jellinger, K. A. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0824-x · Cited by 41
Self-citationIseki, E., Takayama, N., Marui, W., Uéda, K., & Kosaka, K. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00689-x · Cited by 37
Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease
Mochizuki, A., Komatsuzaki, Y., & Shoji, S. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0582-0 · Cited by 33
Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy as α-Synucleinopathies
Goedert, M., Jakes, R., Crowther, R. A., & Spillantini, M. G. (2003) · Humana Press eBooks · doi:10.1385/1-59259-142-6:33 · Cited by 21
Striatal and pontocerebellar hypoperfusion in Hallervorden-Spatz syndrome
Castelnau, P., Zilbovicius, M., Ribeiro, M. J., Hertz‐Pannier, L., de Baulny, H. O., & Evrard, P. (2001) · Pediatric Neurology · doi:10.1016/s0887-8994(01)00295-8 · Cited by 14
Parkinson's disease with late Pick's dementia
Henderson, J. M., Gai, W., Hely, M. A., Reid, W. G. J., Walker, G. L., & Halliday, G. M. (2001) · Movement Disorders · doi:10.1002/mds.1053 · Cited by 14
Cited by
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Parkinson's disease: a dual‐hit hypothesis
Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021
Calderón-Garcidueñas, L., Solt, A. C., Henríquez-Roldán, C., Torres-Jardón, R., Nuse, B., Herritt, L., Villarreal-Calderón, R., Osnaya, N., Stone, I., García, R., et al. (2008) · Toxicologic Pathology · doi:10.1177/0192623307313011 · Cited by 937
Braak, H., Bohl, J. R., Müller, C. M., Rüb, U., de Vos, R. A. I., & Del Tredici, K. (2006) · Movement Disorders · doi:10.1002/mds.21065 · Cited by 630
Metadata
- Authors
- Jellinger, K. A.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2003-09
- Volume
- 18
- Issue
- S6
- Pages
- 2-12
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W1973652068
- Cited by
- 340
- References
- 72
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.